GlassScriptPhysician profile
Subash C Arora
NPI 1245224807
$1,233.74
in general payments reported to CMS, 2019-2025
9 companies · $279 in 2025
The $279 reported for 2025 was more than what 87% of Neonatal-Perinatal Medicine providers received nationally (typical 2025 total: $77.90).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.24 · 2020: $15.86 · 2021: $121 · 2022: $209 · 2023: $334 · 2024: $187 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $800.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $371.64 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Sanofi Pasteur INC. | $253.35 | 2021-2025 | |
| Cranial Technologies, INC | $179.96 | 2019-2025 | Doc Band |
| Sanofi-Aventis U.S. LLC | $133.58 | 2025 | |
| Pfizer INC. | $89.15 | 2019-2024 | |
| Neurelis, INC. | $77.32 | 2022-2023 | Valtoco |
| Sobi, INC | $75.02 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $29.38 | 2019-2021 | |
| Ars Pharmaceuticals Operations, INC. | $24.34 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Subash Arora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.